KELLY CANERDAY: Open Payments
NPI 1952744963 · OAK LAWN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 20 payments from 9 companies in 2025. Trend: 2023 $851 · 2024 $1,035 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| Novo Nordisk Inc | 4 | $82 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| Exact Sciences Corporation | 2 | $40 |
| ABBVIE INC. | 2 | $38 |
| Dexcom, Inc. | 1 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: Ozempic, TRELEGY ELLIPTA, BREZTRI, Dexcom G6 Transmitter, Rybelsus, The Cologuard Plus Collection Kit, QULIPTA, FARXIGA.
Industry payments across IL — which companies pay providers there.
